Opinion EDITORIAL Osteoporosis Screening—2 Steps May Be Too Much for Women Younger Than 65 Years Margaret L. Gourlay, MD, MPH The 2018 US Preventive Services Task Force (USPSTF) osteo- The NNS estimates are not available for a 2-step screening procedure, but they would be higher because the FRAX fracture porosis screening statement includes separate B recommen- dations (moderate certainty of moderate net benefit) for bone risk assessment tool most often proposed for prescreening density screening in women performs only modestly better than chance to identify post- 65 years or older and in post- menopausal women aged 50 to 64 years with femoral neck menopausal women younger osteoporosis. Also, a prescreening step does not ensure selec- Related articles at jama.com than 65 years who are at in- tionofapatientpopulationmorelikelytobenefitfromtreatment. creased risk of osteoporosis, For example, a 2001 randomized clinical trial demonstrated that as determined by a formal clinical risk assessment tool. The B risedronate significantly reduced the risk of hip fracture among recommendation for routine osteoporosis screening in all women aged 80 years or older with confirmed osteoporosis, but women 65 years or older has been an enduring and evidence- not among women aged 70 to 79 years selected primarily based
JAMA Internal Medicine – American Medical Association
Published: Sep 26, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera